Australia's Nanosonics rises on strong show of biofilm removal technology
** Shares of disinfectant devices maker Nanosonics NAN.AX
rise as much as 2.87% to A$2.87, their highest since May 29
** Co says a new study shows that its CORIS technology
outperforms manual cleaning in biofilm removal in endoscopes
** "The CORIS technology represents a significant
opportunity to improve patient safety" - CEO & President,
Michael Kavanagh
** Stock has fallen 36.59% this year, as of last close
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
Recent news on NANOSONICS
See all newsBrief: Nanosonics Announces Second FDA 510(K) Clearance For Coris System
Australia's Nanosonics hits 2-year low on forecast miss
Brief: Nanosonics Posts FY Net Income Attributable Of AUD 17.8 Million
Australia's Nanosonics set for worst day in over two months on weak interim profit
Morningstar sees Nanosonics' endoscope-cleaning device supporting recurring revenue